Filing Details
- Accession Number:
- 0001209191-20-025596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-24 16:17:27
- Reporting Period:
- 2020-04-22
- Accepted Time:
- 2020-04-24 16:17:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1334365 | Yuchun Lee | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-04-22 | 2,000 | $57.27 | 3,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-22 | 300 | $265.16 | 3,575 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-22 | 300 | $266.18 | 3,275 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-22 | 507 | $267.34 | 2,768 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-22 | 224 | $268.48 | 2,544 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-22 | 300 | $269.47 | 2,244 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-22 | 369 | $270.54 | 1,875 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2020-04-23 | 2,000 | $57.27 | 3,875 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-04-23 | 353 | $267.47 | 3,522 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-23 | 200 | $269.23 | 3,322 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-23 | 300 | $271.03 | 3,022 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-23 | 100 | $272.55 | 2,922 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-23 | 400 | $274.23 | 2,522 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-23 | 600 | $275.90 | 1,922 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-23 | 47 | $276.45 | 1,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-22 | 2,000 | $0.00 | 2,000 | $57.27 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-04-23 | 2,000 | $0.00 | 2,000 | $57.27 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 7,125 | 2022-09-13 | No | 4 | M | Direct | |
| 5,125 | 2022-09-13 | No | 4 | M | Direct |
Footnotes
- Transaction made pursuant to Mr. Lee's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $265.16 (range $264.63 to $265.55).
- Mr. Lee undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $266.18 (range $265.84 to $266.83).
- Open market sales reported on this line occurred at a weighted average price of $267.34 (range $267.09 to $267.67).
- Open market sales reported on this line occurred at a weighted average price of $268.48 (range $268.15 to $269.10).
- Open market sales reported on this line occurred at a weighted average price of $269.47 (range $269.23 to $269.60).
- Open market sales reported on this line occurred at a weighted average price of $270.54 (range $270.28 to $270.91).
- Open market sales reported on this line occurred at a weighted average price of $267.47 (range $267.04 to $267.97).
- Open market sales reported on this line occurred at a weighted average price of $269.23 (range $268.80 to $269.66).
- Open market sales reported on this line occurred at a weighted average price of $271.03 (range $270.69 to $271.65).
- Open market sales reported on this line occurred at a weighted average price of $274.23 (range $273.69 to $274.66).
- Open market sales reported on this line occurred at a weighted average price of $275.90 (range $275.44 to $276.40).
- Fully vested.
Billionaire Hedge Funds
